Innovation for Health - 13 February 2020
Contact Investor Forum I4H Bootcamp
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Maurits van Selms

Co-promotor of doctoral students, ACTA & ALS (Amyotrophic Lateral Sclerosis)-patient
Maurits van Selms

Plenary programme

13:30 - 14:00
Panel discussion 'Right to Try' - access to experimental treatment

After studying one year at KU Leuven, Maurits Karel Adriaan van Selms (1974) started in 1995 the study dentistry in Amsterdam (ACTA). The route towards becoming a dentist was blocked when the neuromuscular disease Amyotrophic Lateral Sclerosis (ALS) was diagnosed in 1998. In 2001, Maurits filed a lawsuit against a pharmaceutical company to gain access to an unregistered drug. Since 2007, when he received his PhD degree, Maurits is tenured as researcher and lecturer. Various publications and presentations at scientific conferences have earned him a positive reputation. Maurits is currently designated as co-promotor of doctoral students. Despite the breadth of challenges disabled academics face, Maurits is a good example that it is possible to lead a meaningful and qualitatively good live.
Tim Knotnerus
AgomAb Therapeutics
Elise Meijer
Antwerp Management School & Accenture Strategy
Esther Talboom-Kamp
Saltro
Joep Muijrers
PureTech Health
Els Beirnaert
Aelin Therapeutics
Carine van den Brink
Axon Lawyers

Claudia Rijcken
pharmi

Harald Schmidt
Maastricht University

Rajiv Vaid Basaiawmoit
Aarhus University & Biosymfonix
Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Gold sponsor
Award sponsor
AXON Lawyers
You?
Become a Sponsor!
Powered by
Hyphen Projects
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.